Individuals With Advanced Breast Cancer at Diagnosis More Likely to Have CVD

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 7, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 6, 2025 -- Individuals with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease (CVD), according to a study published online Jan. 2 in JAMA Network Open.

In a population-based case-control study, Ivan Angelov, from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined whether female patients aged at least 66 years presenting with advanced breast cancers are more likely to have prevalent CVD compared with those with early-stage breast cancer at the time of diagnosis.

The full analytic cohort included 19,292 matched female patients; 9,478 had prevalent CVD. The researchers found that the odds of prevalent CVD were significantly increased in individuals with locally advanced or metastatic cancer at diagnosis in propensity score-matched, multivariable-adjusted models (odds ratio, 1.10; 95 percent confidence interval, 1.03 to 1.17; P = 0.007). This association was seen for hormone receptor-positive breast cancer (odds ratio, 1.11; 95 percent confidence interval, 1.03 to 1.19; P = 0.006), but not hormone receptor-negative (odds ratio, 1.02; 95 percent confidence interval, 0.86 to 1.21; P = 0.83). When examining locally advanced and metastatic disease separately, odds ratios were directionally consistent (odds ratios [95 percent confidence intervals], 1.09 [1.02 to 1.17; P = 0.02] and 1.20 [0.94 to 1.54; P = 0.15], respectively) among all receptor subtypes.

"This retrospective case-control study found an association between prevalent CVD and more advanced stage of breast cancer at diagnosis, independent of factors associated with delayed diagnosis and shared risk," the authors write.

One author disclosed ties to Artidis Research, Varian Medical Systems, and Oncora Medical.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords